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Smith, K.E., Borden, L.A., Hartig, P.R., Branchek, T., and Weinshank, mechanisms that fail in aging. Much progress in this
R.L. (1992). Neuron 8, 927–935. regard has been made based on animal models of hippo-
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the development of agents that should improve hippo-
campal-dependent memory when it is impaired by
aging. Compounds that inhibit cAMP breakdown,
thereby increasing protein kinase A (PKA) activation,
have been reported to improve physiological and behav-Age-Related Memory
ioral indices of hippocampal-dependent memory inImpairment: Is the Cure
aged mice (Barad et al., 1998; Bach et al., 1999). If one
Worse than the Disease? assumes that age-related impairment in hippocampal-
dependent memory processing in rodents is a good
model for cognitive aging in humans, then this predicts
that such agents will also benefit memory function inAging impairs multiple memory systems. The neuro-
aged humans, possibly including those that have mem-chemical substrates of normal memory differ between
ory deficits stemming from pathological conditions as-memory systems. In this issue of Neuron, Ramos et
sociated with aging (such as Alzheimer’s disease).al. find that activation of protein kinase A, which has
Although much has been learned about the neuralbeen reported to improve hippocampal-dependent
bases of age-related memory impairment by studyingspatial memory in aged animals, has the opposite ef-
neurobiological correlates of impaired hippocampal-fect on prefrontal cortex-dependent working memory
dependent memory in aging, this approach neglects thein aged animals.
contribution of other brain systems. Impaired prefrontal
function also occurs in aging, and disruption of workingOne of the major discoveries of neuropsychology and
memory and other aspects of executive function posesbehavioral neuroscience in the last 50 years is the exis-
a challenge for aged individuals. Comparatively little istence of multiple memory systems. Different aspects of
known about the biological substrates of age-relatedmemory are affected by damage to different brain re-
impairments in prefrontal memory function.gions (Eichenbaum and Cohen, 2001). This research pro-
Because PKA activation improves hippocampal-
vides a foundation for understanding the neurobiologi-
dependent memory in aged rodents, it is important to
cal substrates of memory processing—in order to
understand the consequences of this treatment on other
understand the cellular and molecular processes that
memory systems. In this issue of Neuron, Ramos et al.
underlie memory, one must know where to look.
examined the effects of PKA activation and inhibition
Aging impairs both hippocampal-dependent and pre-
on prefrontal-dependent working memory in aged rats
frontal-dependent memory function, as well as other and monkeys. Earlier work from this group had shown
cognitive domains (Gallagher and Rapp, 1997). Cogni- that PKA activation in prefrontal cortex of young rats
tive aging does not appear to be the result of a homoge- impaired working memory (Taylor et al., 1999), similar to
neous disruption of brain function: age-related impair- the effect of overstimulation of dopamine D1 receptors
ments in hippocampal-dependent memory appear, at (Zahrt et al., 1997). This is perhaps not surprising, as it
least to some extent, to be independent of age-related is suggestive of a canonical U-shaped dose-response
impairments in prefrontal function (e.g., Barense et al., curve in which optimal dopamine receptor stimulation
2002). While acknowledging that there are theoretical is necessary for normal working memory (Zahrt et al.,
uncertainties with the concepts of independent memory 1997). However, the prediction for the situation in the
systems (Gaffan, 2002) and that these areas are involved aged brain is anything but clear. Given that dopamine
in other aspects of memory and cognition besides epi- levels in prefrontal cortex decrease in aging, it might
sodic and working memory (e.g., Duncan and Owen, be expected that stimulation of PKA activity would be
2000), there is compelling physiological evidence for beneficial to working memory. This would be a welcome
correlates of these two different processes within these state of affairs, because PKA stimulation would improve
two cortical areas. Hippocampal neurons encode mem- both prefrontal- and hippocampal-dependent memory.
ory “episodes,” complex conjunctions of spatial and/or The findings of Ramos et al. on PKA regulation and
temporal information (e.g., Wood et al., 2000). Neurons working memory in aged animals are in striking contrast
in dorsolateral prefrontal cortex possess “memory to the effects of PKA activation on hippocampal-depen-
fields” for spatial locations in monkeys performing a dent spatial memory. Figure 1 illustrates a simplified
task requiring working memory for one of a number of schematic of PKA regulation, along with the points in
spatial locations (e.g., Funahashi et al., 1989). Notably, the pathway targeted by the different pharmacological
short-term memory for spatial location does not require agents used by Ramos et al. Activation of PKA in pre-
an intact hippocampus (Angeli et al., 1993), supporting frontal cortex of aged rats by direct infusion of Sp-
the notion of some independence between these CAMPS into the prefrontal cortex impairs working mem-
systems. ory, whereas PKA inhibition by infusion of Rp-CAMPS
The localization of different memory processes in dif- facilitates it. These effects are more pronounced in rats
ferent cortical areas, and the understanding of their bio- that show greater impairment in performing the working
memory task: thus, rats with more impaired prefrontalchemical and physiological underpinnings, promises
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prove hippocampal-dependent memory function, if doses
can be found that do not impair prefrontal function. One
is encouraged in this regard by the relative lack of effect
of rolipram on working memory in the young monkeys
tested by Ramos et al. However, for aged subjects expe-
riencing cognitive impairments that involve the frontal
lobe—deficits in working memory, as well as other as-
pects of executive function and cognitive control—PKA
activators are likely to exacerbate these problems, not
relieve them.
This study highlights the promise of basic behavioral
neuroscience research on the neuroanatomy and neuro-
biology of memory function—by taking an understand-
Figure 1. A Greatly Simplified Schematic of PKA Regulation
ing of the neurochemical mechanisms of working mem-
Gs-coupled receptors (such as the dopamine D1 receptor) activate ory derived from lesion and pharmacological studies inadenylate cyclase (AC), which converts ATP to cyclic AMP (cAMP).
rodents and primates, Ramos et al. have applied thiscAMP in turn activates PKA, which goes on to have various effects
knowledge to an important public health problem—theon the neuron, including phosphorylation of CREB (cyclic AMP re-
sponse element binding protein). Gi-coupled receptors (such as the amelioration of cognitive impairment in aging. It may be
2 norepinephrine receptor) inhibit AC, reducing cAMP levels and the case that brain-wide PKA enhancement in elderly
thence PKA activity. Phosphodiesterase type 4 (PDE4) breaks down humans will produce overall improvement in memory
cAMP, removing its ability to activate PKA. Ramos et al. (2003) used function and in activities of daily life, if impairments in
infusions of either Sp-cAMPS or Rp-cAMPS into prefrontal cortex
prefrontal function are offset by improvements in hippo-to directly activate or inhibit (respectively) PKA. Sp-CAMPS impairs
campal function. Ultimately, the test will come fromworking memory in aged rats, and Rp-CAMPS improves it. For sys-
studies of these agents in the clinic. However, shouldtemic studies in aged monkeys, rolipram was used to inhibit PDE4,
allowing greater cAMP accumulation and thus greater PKA activa- these drugs prove disappointing for treating age-related
tion. Rolipram impairs working memory in aged monkeys. cognitive impairments, it may be that agents can be
found that will be able to affect PKA selectively in differ-
ent brain regions, perhaps by identifying region-specific
function have more severe dysregulation of PKA. Sys-
regulatory mechanisms of PKA.
temic administration of rolipram, a PDE4 inhibitor that
increases PKA activity by limiting breakdown of cAMP,
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